Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 96,713 | 72,797 | 407 | N/A | N/A |
| TOTAL | $100,083 | $74,095 | $1,338 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 9,205 | 10,546 | 2,942 | N/A | N/A |
| Other Non-Current Assets | 1,151 | 1,130 | 60 | 0 | 0 |
| TOTAL | $10,356 | $11,676 | $3,002 | $N/A | $N/A |
| Total Assets | $110,439 | $85,771 | $4,340 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,186 | 1,263 | 1,673 | 0 | 0 |
| Accrued Expenses | 5,496 | 2,497 | 1,112 | N/A | N/A |
| TOTAL | $12,140 | $4,229 | $2,785 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,458 | 469 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 5,135 | 5,542 | 233 | 0 | 0 |
| TOTAL | $11,146 | $5,542 | $233 | $N/A | $N/A |
| Total Liabilities | $23,286 | $9,771 | $3,018 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,357 | N/A | N/A | N/A | N/A |
| Common Shares | 23 | 2 | 1 | N/A | N/A |
| Retained earnings | -150,801 | -68,124 | -35,536 | N/A | N/A |
| Other shareholders' equity | 0 | 139,670 | 34,587 | 0 | 0 |
| TOTAL | $87,153 | $76,000 | $1,322 | $N/A | $N/A |
| Total Liabilities And Equity | $110,439 | $85,771 | $4,340 | $0 | $0 |